Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,648 | 203 | 75.1% |
| Travel and Lodging | $1,545 | 6 | 24.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,678 | 28 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $813.35 | 31 | $0 (2024) |
| Medtronic, Inc. | $477.00 | 25 | $0 (2024) |
| Zyla Life Sciences, Inc. | $368.19 | 47 | $0 (2020) |
| UROGEN PHARMA, INC. | $255.21 | 14 | $0 (2024) |
| COLOPLAST CORP | $184.77 | 7 | $0 (2024) |
| Axonics, Inc. | $177.78 | 3 | $0 (2023) |
| Medtronic USA, Inc. | $153.28 | 2 | $0 (2020) |
| Antares Pharma, Inc. | $121.10 | 6 | $0 (2024) |
| PFIZER INC. | $93.64 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $595.46 | 24 | Medtronic, Inc. ($108.12) |
| 2023 | $626.42 | 28 | Endo Pharmaceuticals Inc. ($177.54) |
| 2022 | $565.61 | 29 | Medtronic, Inc. ($173.09) |
| 2021 | $1,193 | 42 | BOSTON SCIENTIFIC CORPORATION ($297.21) |
| 2020 | $652.73 | 56 | Zyla Life Sciences, Inc. ($338.11) |
| 2019 | $454.39 | 11 | Boston Scientific Corporation ($166.48) |
| 2018 | $1,236 | 17 | BOSTON SCIENTIFIC CORPORATION ($1,185) |
| 2017 | $869.67 | 2 | BOSTON SCIENTIFIC CORPORATION ($869.67) |
All Payment Transactions
209 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/10/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/06/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/25/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/23/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/11/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $16.78 | General |
| Category: Urology | ||||||
| 08/28/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: UROLOGY | ||||||
| 08/26/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $31.13 | General |
| Category: UROLOGY | ||||||
| 08/14/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: UROLOGY | ||||||
| 07/25/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 07/23/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $36.52 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 07/22/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: UROLOGY | ||||||
| 07/08/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 07/02/2024 | Boston Scientific Corporation | AMS 700 (Device) | Food and Beverage | In-kind items and services | $72.63 | General |
| Category: AMS 700_URO | ||||||
| 06/10/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 05/20/2024 | KARL STORZ Endoscopy-America | — | Food and Beverage | In-kind items and services | $25.07 | General |
| 05/09/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $36.51 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 04/12/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: UROTHELIAL CANCER | ||||||
| 04/11/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $30.91 | General |
| Category: Prostate cancer | ||||||
| 04/10/2024 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: UROLOGY | ||||||
| 04/08/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: UROLOGY | ||||||
| 02/29/2024 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $32.50 | General |
| Category: UROLOGY | ||||||
| 02/29/2024 | COLOPLAST CORP | Coloplast TFL Drive (Device) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Endourology | ||||||
| 02/28/2024 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: UROLOGY | ||||||
| 02/07/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $17.08 | General |
| Category: UROLOGY | ||||||
| 12/07/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Sacral Nerve Stimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 782 | 1,066 | $100,669 | $44,567 |
| 2022 | 18 | 794 | 1,013 | $100,951 | $46,796 |
| 2021 | 9 | 294 | 370 | $43,364 | $22,228 |
| 2020 | 8 | 347 | 434 | $60,340 | $16,448 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 166 | 260 | $46,800 | $20,877 | 44.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 65 | 65 | $14,300 | $7,081 | 49.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 25 | 28 | $12,600 | $4,444 | 35.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 72 | $8,280 | $4,422 | 53.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 21 | 21 | $3,885 | $1,963 | 50.5% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 24 | 35 | $1,925 | $885.15 | 46.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $1,595 | $850.14 | 53.3% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 41 | 45 | $1,575 | $810.90 | 51.5% |
| 82670 | Measurement of total estradiol (hormone) | Office | 2023 | 20 | 29 | $1,015 | $794.02 | 78.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 143 | 215 | $1,505 | $469.05 | 31.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 50 | 69 | $3,450 | $468.09 | 13.6% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 44 | 55 | $852.50 | $434.49 | 51.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 43 | 59 | $413.00 | $404.74 | 98.0% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 21 | 26 | $442.00 | $220.48 | 49.9% |
| 87088 | Bacterial urine culture | Office | 2023 | 21 | 26 | $676.00 | $206.18 | 30.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 19 | $1,045 | $165.12 | 15.8% |
| 85014 | Red blood cell concentration measurement | Office | 2023 | 20 | 31 | $310.00 | $71.92 | 23.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 170 | 245 | $44,100 | $21,912 | 49.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 77 | 77 | $17,060 | $8,300 | 48.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 26 | 26 | $11,700 | $4,708 | 40.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 53 | 61 | $7,015 | $3,698 | 52.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 22 | 22 | $4,070 | $2,259 | 55.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 17 | 17 | $2,500 | $1,205 | 48.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 69 | 87 | $4,350 | $637.76 | 14.7% |
| 84403 | Testosterone (hormone) level, total | Office | 2022 | 18 | 25 | $1,375 | $617.24 | 44.9% |
About Dr. David Qi, M.D
Dr. David Qi, M.D is a Urology healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2013. The National Provider Identifier (NPI) number assigned to this provider is 1760826952.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Qi, M.D has received a total of $6,193 in payments from pharmaceutical and medical device companies, with $595.46 received in 2024. These payments were reported across 209 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($4,648).
As a Medicare-enrolled provider, Qi has provided services to 2,217 Medicare beneficiaries, totaling 2,883 services with total Medicare billing of $130,038. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Urology, Urology
- Location Birmingham, AL
- Active Since 04/18/2013
- Last Updated 07/11/2024
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1760826952
Products in Payments
- AMS (Device) $1,295
- GENERAL - ERECTILE DYSFUNCTION (Device) $925.26
- XIAFLEX (Biological) $773.76
- INTERSTIM (Device) $630.28
- SPRIX (Drug) $368.19
- JELMYTO (Drug) $255.21
- AMS 700 CXR RTE KIT (Device) $218.42
- GEMTESA (Drug) $137.57
- BOTOX (Biological) $131.08
- Axonics r-SNM System (Device) $110.32
- Titan (Device) $108.46
- XYOSTED (Drug) $94.03
- UroLift (Device) $91.45
- XTANDI (Drug) $77.93
- AVEED (Biological) $74.75
- AMS 700 (Device) $72.63
- Bulkamid (Device) $53.70
- AdVance XP (Device) $50.45
- VaPro (Device) $49.12
- AQUABEAM SYSTEM (Device) $48.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Birmingham
Dr. Thomas Chi, Md, MD
Urology — Payments: $470,805
Dr. Joel Funk, M.d, M.D
Urology — Payments: $338,628
Dr. Adam Baumgarten, M.d, M.D
Urology — Payments: $173,495
Kyle Wood
Urology — Payments: $81,887
Jeffrey Nix, M.d, M.D
Urology — Payments: $46,718
Charles Peyton
Urology — Payments: $16,163